ASX:PNV PolyNovo (PNV) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About PolyNovo Stock (ASX:PNV) 30 days 90 days 365 days Advanced Chart Get PolyNovo alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume3.38 million shsAverage VolumeN/AMarket CapitalizationA$1.30 billionP/E Ratio247.31Dividend Yield6.86%Price TargetN/AConsensus RatingN/A Company Overview PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; NovoSorb Dermal Beta Cell Implant to host pancreatic islet cells in the skin; NovoSorb MTX for the treatment of varying complex wounds; and plastics and reconstructive device product. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia. Read More Receive PNV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PolyNovo and its competitors with MarketBeat's FREE daily newsletter. Email Address PNV Stock News HeadlinesMacquarie predicts 86% upside for this ASX 200 healthcare stockJuly 30, 2025 | msn.comGuess which ASX 200 stock is jumping 11% todayJuly 30, 2025 | msn.comGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control. Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live.August 10 at 2:00 AM | Priority Gold (Ad)Are PolyNovo Limited's (ASX:PNV) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?July 13, 2025 | finance.yahoo.comThese were the worst performing ASX 200 shares in FY 2025July 1, 2025 | msn.comWhat Does PolyNovo Limited's (ASX:PNV) Share Price Indicate?June 17, 2025 | finance.yahoo.comThese ASX growth shares could rise 18% to 30%May 29, 2025 | msn.comScott Power: ASX health stocks up as Trump’s bark proves worse than biteMay 16, 2025 | msn.comSee More Headlines PNV Stock Analysis - Frequently Asked Questions What other stocks do shareholders of PolyNovo own? Based on aggregate information from My MarketBeat watchlists, some other companies that PolyNovo investors own include Align Technology (ALGN), Amgen (AMGN), Docusign (DOCU), Panoramic Resources (PAN), Plug Power (PLUG) and Roku (ROKU). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:PNV CIKN/A Webwww.polynovo.com.au Phone61 3 8681 4050FaxN/AEmployees237Year FoundedN/AProfitability EPS (Trailing Twelve Months)A$0.01 Trailing P/E Ratio247.31 Forward P/E RatioN/A P/E Growth2.63Net IncomeA$5.26 million Net Margins5.10% Pretax MarginN/A Return on Equity7.45% Return on Assets0.56% Debt Debt-to-Equity Ratio21.32 Current Ratio3.41 Quick Ratio1.58 Sales & Book Value Annual SalesA$103.23 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow207.50 Book ValueA$0.10 per share Price / BookN/AMiscellaneous Outstanding Shares690,760,000Free FloatN/AMarket CapA$1.30 billion OptionableNot Optionable Beta1.67 10 Stocks Set to Soar in Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (ASX:PNV) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 17th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PolyNovo Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share PolyNovo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
